Health Technology · Pharmaceuticals: Major · NSE: SOTAC · data 2026-10-09

Sotac Pharmaceuticals Limited

Health check: Strong (6.6/10 on quality, valuation vs sector, growth and momentum).

Open full analysis — chart, results, balance sheet, red flags →

Key figures

Price

₹90.05

Market cap

₹100 cr

P/E

17.3

P/B

1.7

ROE

10.3%

ROCE

17.4%

Debt / equity

0.64

Dividend yield

0.22%

1-year return

-20.7%

52-week high

₹139.65

52-week low

₹86

Operating margin

8.6%

Growth

Revenue (last 12 months)	₹97 cr
Net profit (last 12 months)	₹6 cr
Sales growth, 3 years (yearly)	9.3%
Profit growth, 3 years (yearly)	26.1%

Similar companies

Parnax Lab Limited (PARNAXLAB) · Krebs Biochemicals & Industries Ltd. (KREBSBIO) · Alpa Laboratories Limited (ALPA) · Makers Laboratories Ltd (MAKERSL) · Vaishali Pharma Ltd. (VAISHALI)

The full analysis has the price chart, every quarterly result with YoY/QoQ growth, the balance sheet and cash flow with an accounting red-flag check, shareholding quarter by quarter with big investors, news, filings and bulk/block deals.

Open SOTAC in NSE Scanner →